<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">World J Cardiol</journal-id><journal-id journal-id-type="publisher-id">WJC</journal-id><journal-title-group><journal-title>World Journal of Cardiology</journal-title></journal-title-group><issn pub-type="epub">1949-8462</issn><publisher><publisher-name>Baishideng Publishing Group Inc</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28603588</article-id><article-id pub-id-type="pmc">5442409</article-id><article-id pub-id-type="other">jWJC.v9.i5.pg416</article-id><article-id pub-id-type="doi">10.4330/wjc.v9.i5.416</article-id><article-categories><subj-group subj-group-type="heading"><subject>Minireviews</subject></subj-group></article-categories><title-group><article-title>Transcervical access, reversal of flow and mesh-covered stents: New options in the armamentarium of carotid artery stenting</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Paraskevas</surname><given-names>Kosmas I</given-names></name></contrib><contrib contrib-type="author"><name><surname>Veith</surname><given-names>Frank J</given-names></name></contrib><aff>Kosmas I Paraskevas, Northern Vascular Centre, Freeman Hospital, Newcastle-upon-Tyne NE7 7DN, United Kingdom</aff><aff>Frank J Veith, Divisions of Vascular Surgery, New York University Langone Medical Center, New York, NY 10016, United States</aff><aff>Frank J Veith, the Cleveland Clinic, Cleveland, OH 44195, United States</aff></contrib-group><author-notes><fn><p>Author contributions: Paraskevas KI came up with the idea/topic of the manuscript, searched the literature and wrote the first draft of the manuscript; Veith FJ revised the manuscript and suggested improvements.</p><p>Correspondence to: Kosmas I Paraskevas, MD, PhD, Northern Vascular Centre, Freeman Hospital, Freeman Road, Newcastle-upon-Tyne NE7 7DN, United Kingdom. <email>paraskevask@hotmail.com</email></p><p>Telephone: +44-73-76104373</p></fn></author-notes><pub-date pub-type="ppub"><day>26</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>26</day><month>5</month><year>2017</year></pub-date><volume>9</volume><issue>5</issue><fpage>416</fpage><lpage>421</lpage><history><date date-type="received"><day>14</day><month>12</month><year>2016</year></date><date date-type="rev-recd"><day>10</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>21</day><month>3</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9;The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p><!--CREATIVE COMMONS-->Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link></license-p></license></permissions><abstract><p>In the last 25 years, the very existence of carotid artery stenting (CAS) has been threatened on a number of occasions. The initial disappointing results that even lead to the discontinuation of an early randomized controlled trial have improved considerably with time. Novel devices, advanced stent and equipment technology, alternative types of access and several types of filters/emboli protecting devices have been reported to reduce stroke/death rates during/after CAS and improve CAS outcomes. The present review will provide a description of the various technology advances in the field that aim to reduce stroke and death rates associated with CAS. Transcervical access, reversal of flow and mesh-covered stents are currently the most promising tools in the armamentarium of CAS.</p></abstract><kwd-group><kwd>Carotid artery stenting</kwd><kwd>Stroke</kwd><kwd>Carotid artery stenosis</kwd><kwd>Filters</kwd></kwd-group></article-meta></front><body><p><bold>Core tip:</bold> Carotid artery stenting (CAS) has improved considerably in the last few years. This comprehensive review provides the various technology advances in the field that aim to reduce stroke and death rates after CAS. These include transcervical access, reversal of flow and mesh-covered stents.</p><sec><title>INTRODUCTION</title><p>During its evolution, carotid artery stenting (CAS) has often gone through some difficult times. One of the first randomized controlled trials comparing CAS with carotid endarterectomy (CEA), the Leicester trial, had to be stopped prematurely after randomizing less than 20 patients[<xref rid="B1" ref-type="bibr">1</xref>]. All 10 patients that were randomized to CEA proceeded without complications. On the other hand, 5 of the 7 patients who were randomized to CAS suffered a stroke (<italic>P</italic> = 0.0034), three of which were disabling at 30 d[<xref rid="B1" ref-type="bibr">1</xref>].</p><p>Fortunately, CAS outcomes have improved considerably since then and continue to improve constantly. Technological advances such as proximal/distal embolic protection devices (EPDs), flow reversal, transcervical/transradial access and double layer mesh stent technology are adjuncts that have been developed to improve CAS outcomes. The current article presents an overview of these technological advances.</p></sec><sec><title>EPDS</title><p>Proximal and distal EPDs are commonly utilized with CAS with the aim of preventing atherosclerotic debris from embolizing to the brain. Catheter manipulation within the aorta and supra-aortic arteries causes plaque embolization. Up to 90% of CAS procedures can be complicated by embolic events and EPDs may capture these embolized particles[<xref rid="B2" ref-type="bibr">2</xref>]. Although some studies report good outcomes for various distal EPDs (also known as filtering devices)[<xref rid="B3" ref-type="bibr">3</xref>-<xref rid="B5" ref-type="bibr">5</xref>], others studies argue that distal filters may not be able to prevent all perioperative emboli[<xref rid="B6" ref-type="bibr">6</xref>-<xref rid="B9" ref-type="bibr">9</xref>]. The pore size of most available filter devices is &#x0003e; 80 &#x003bc;m[<xref rid="B3" ref-type="bibr">3</xref>], but many emboli are &#x0003c; 80 &#x003bc;m in size[<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B11" ref-type="bibr">11</xref>]. Furthermore, due to the rigidity of many filter devices and a required minimal distal landing zone depending on the length of the basket of the filter device, the vessel wall apposition may not be optimal (especially in tortuous vessel segments) and could therefore allow cerebral embolization[<xref rid="B12" ref-type="bibr">12</xref>]. These studies have supported that, compared with distal EPDs, proximal EPDs reduce the perioperative microembolic signals detected by transcranial Doppler and the number of new ischemic lesions[<xref rid="B6" ref-type="bibr">6</xref>-<xref rid="B9" ref-type="bibr">9</xref>].</p><p>A study from Milan, Italy compared the rate of cerebral microembolization during CAS with a proximal EPD [Mo.Ma system (Invatec, Roncadelle, Brescia, Italy); <italic>n</italic> = 26] <italic>vs</italic> distal protection with a filter [FilterWire EZ (Boston Scientific Corporation, Santa Clara, California); <italic>n</italic> = 27] in patients with high-risk, lipid-rich plaques[<xref rid="B7" ref-type="bibr">7</xref>]. Compared with use of the FilterWire EZ, the Mo.Ma system significantly reduced mean microembolic signal counts during lesion crossing (mean: 18 <italic>vs</italic> 2, respectively; <italic>P</italic> &#x0003c; 0.0001), stent crossing (mean: 23 <italic>vs</italic> 0, respectively; <italic>P</italic> &#x0003c; 0.0001), stent deployment (mean: 30 <italic>vs</italic> 0, respectively; <italic>P</italic> &#x0003c; 0.0001), stent dilation (mean: 16 <italic>vs</italic> 0, respectively; <italic>P</italic> &#x0003c; 0.0001) and total microembolic signals (mean: 93 <italic>vs</italic> 16, respectively; <italic>P</italic> &#x0003c; 0.0001)[<xref rid="B7" ref-type="bibr">7</xref>].</p><p>The Mo.Ma proximal EPD is a safe and effective neuroprotection system during CAS that achieves very low periprocedural stroke rates. A registry of 1300 patients undergoing CAS using the Mo.Ma device reported very low major adverse cardiac or cerebrovascular events including 5 deaths (0.38%), 6 major strokes (0.46%), 5 minor strokes (0.38%) and 0 myocardial infarctions (MIs)[<xref rid="B13" ref-type="bibr">13</xref>]. The incidence of postprocedural events did not increase even in the presence of theoretical anatomical contraindications to proximal endovascular occlusion (<italic>e.g</italic>., contralateral carotid occlusion). The excellent results reported for the Mo.Ma device suggest that it is a promising technique for the achievement of low stroke rates after CAS.</p><p>A prospective randomized study, the Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting study, compared the embolic load of filter-protected (<italic>n</italic> = 31) <italic>vs</italic> proximal balloon-protected CAS (<italic>n</italic> = 31)[<xref rid="B9" ref-type="bibr">9</xref>]. Proximal balloon occlusion lead to a considerable reduction in the percentage of new cerebral ischemic lesions (45.2% <italic>vs</italic> 87.1%, for proximal balloon occlusion <italic>vs</italic> filter protection, respectively; <italic>P</italic> = 0.001). Proximal balloon occlusion reduced both the number [median (range): 2 (0-13) <italic>vs</italic> 0 (0-4); <italic>P</italic> = 0.0001] and the volume [0.47 (0-2.4) cm<sup>3</sup>
<italic>vs</italic> 0 (0-0.84) cm<sup>3</sup>; <italic>P</italic> = 0.0001] of new cerebral ischemic lesions. Furthermore, contralateral hemisphere lesions were detected in 29.0% <italic>vs</italic> 6.5% of patients receiving a filter <italic>vs</italic> balloon occlusion, respectively (<italic>P</italic> = 0.047). Finally, the 30-d major adverse cardiovascular and cerebral events rate was 3.2% for filter protection <italic>vs</italic> 0% for balloon occlusion, respectively (<italic>P</italic> = not significant)[<xref rid="B9" ref-type="bibr">9</xref>].</p><p>A meta-analysis (<italic>n</italic> = 8 studies; 357 patients) evaluated and compared the results of filter cerebral protection <italic>vs</italic> proximal balloon occlusion in preventing embolization during CAS as evaluated by diffusion-weighted magnetic resonance imaging (DW-MRI)[<xref rid="B14" ref-type="bibr">14</xref>]. The incidence of new ischemic lesions after CAS/patient detected by DW-MRI (effect size: -0.43; 95%CI: -0.84 to -0.02; <italic>I</italic><sup>2</sup> = 70.08; <italic>Q</italic> = 23.40) and the incidence of contralateral site lesions (effect size: -0.50; 95%CI: -0.72 to -0.27; <italic>I</italic><sup>2</sup> = 0.00; <italic>Q</italic> = 3.80) were both significantly lower in the proximal balloon occlusion group[<xref rid="B14" ref-type="bibr">14</xref>]. The results of this meta-analysis support the superiority of proximal balloon occlusion as compared with filter cerebral protection with respect to the degree of CAS-related brain embolization[<xref rid="B14" ref-type="bibr">14</xref>].</p><p>Others, however, have supported that proximal EPDs have similar results with distal filter EPD[<xref rid="B15" ref-type="bibr">15</xref>]. The lack of difference in proximal occlusion <italic>vs</italic> distal filter EPD results was also verified in a meta-analysis[<xref rid="B16" ref-type="bibr">16</xref>]. This meta-analysis included 7 studies (<italic>n</italic> = 392 patients; 193 with proximal occlusion; 199 with distal filters). The use of proximal occlusion <italic>vs</italic> distal filter did not reduce the risk of new cerebral lesions (OR = 0.65; 95%CI: 0.28-1.52; <italic>P</italic> = 0.32) or the risk of death/cerebrovascular event (OR = 0.59; 95%CI: 0.22-1.60; <italic>P</italic> = 0.30)[<xref rid="B16" ref-type="bibr">16</xref>]. A more recent meta-analysis verified the equipoise in clinical outcomes between proximal balloon occlusion and distal filter protection[<xref rid="B17" ref-type="bibr">17</xref>]. This meta-analysis (<italic>n</italic> = 18 studies; 12281 patients) did not demonstrate any significant difference between the two modalities in terms of the risk of stroke or mortality, nor was there any difference in the incidence of new cerebral lesions on DW-MRI or contralateral DW-MRI lesions. The conclusion reached was that both proximal and distal EPDs provide similar levels of protection from periprocedural stroke and 30-d mortality[<xref rid="B17" ref-type="bibr">17</xref>]. Finally, a national cardiovascular data registry analysis from the United States compared stroke/death rates between proximal EPDs and distal filter EPDs in 10,246 consecutive elective CAS procedures. Both EPDs were associated with similar 30-d adverse event rates (2.7% <italic>vs</italic> 4.0%, after proximal <italic>vs</italic> distal filter EPDs, respectively; <italic>P</italic> = 0.22)[<xref rid="B18" ref-type="bibr">18</xref>].</p></sec><sec><title>TRANSCERVICAL ACCESS WITH FLOW-REVERSAL</title><p>The first description of flow reversal as a cerebral protection device was in 2000[<xref rid="B19" ref-type="bibr">19</xref>]. Although initially CAS with flow reversal was performed <italic>via</italic> the transfemoral approach[<xref rid="B19" ref-type="bibr">19</xref>], a subsequent modification was the use of transcervical approach for CAS with flow reversal[<xref rid="B20" ref-type="bibr">20</xref>]. This technique is described in detail elsewhere[<xref rid="B20" ref-type="bibr">20</xref>]. Several independent studies have published very low 30-d stroke/death/MI rates and low incidence of complications for transcervical CAS with flow reversal[<xref rid="B21" ref-type="bibr">21</xref>-<xref rid="B25" ref-type="bibr">25</xref>]. It was recently demonstrated that transcervical CAS with flow reversal demonstrates embolization rates comparable with CEA[<xref rid="B26" ref-type="bibr">26</xref>]. Transcervical CAS with flow reversal thus seems a promising method for the reduction of strokes associated with CAS[<xref rid="B27" ref-type="bibr">27</xref>].</p><p>Elderly patients (&#x0003e; 70 years) have inferior outcomes with transfemoral CAS compared with CEA[<xref rid="B28" ref-type="bibr">28</xref>]. The poor outcome of transfemoral CAS in this age group may be explained by the anatomic characteristics of the aortic trunk and supra-aortic vessels as well as by a high prevalence of aortic arch atheromatosis[<xref rid="B21" ref-type="bibr">21</xref>]. Transcervical CAS with flow reversal for cerebral protection avoids these unfavorable characteristics. An early study reported a 2.2% 30-d combined stroke/death/MI rates in 219 patients &#x0003e; 70 years of age (55.7% asymptomatic; 44.3% symptomatic)[<xref rid="B21" ref-type="bibr">21</xref>]. Symptomatic patients had a 5.1% combined stroke/death/MI rates whereas asymptomatic patients had a 0% rate[<xref rid="B21" ref-type="bibr">21</xref>]. Thus, transcervical CAS with flow reversal may be the preferred option for this age group.</p><p>Not long ago, the Reverse Flow Used During CAS Procedure (ROADSTER) multicenter trial reported its results from the evaluation of the safety and efficacy of the ENROUTE Transcarotid NPS (Silk Road Medical Inc, Sunnyvale, Calif), a novel transcarotid neuroprotection system that provides direct surgical common carotid access and cerebral embolic protection <italic>via</italic> high-rate flow reversal during CAS[<xref rid="B29" ref-type="bibr">29</xref>]. This study reported an overall stroke rate of 1.4%, which is the lowest reported for any prospective multicenter clinical trial of CAS. The stroke/death rates (2.8%) and the stroke/death/MI rates (3.5%) reported were also similarly low[<xref rid="B29" ref-type="bibr">29</xref>].</p><p>Direct percutaneous carotid access is an alternative access that has been described for CAS. This access can be used in individuals with difficult anatomies, high-risk patients and certain emergent situations that warrant easy and rapid access to the CCA[<xref rid="B30" ref-type="bibr">30</xref>]. A systematic review (<italic>n</italic> = 12 studies; 739 CAS procedures) showed that direct CAS with transcervical access (filter protected or unprotected; <italic>n</italic> = 250 patients) and CAS with transcervical access under reversed flow (with arteriovenous shunt in most cases; <italic>n</italic> = 489 patients) are both associated with a low incidence of stroke and complications[<xref rid="B31" ref-type="bibr">31</xref>]. The incidence of stroke, MI and death was 1.1%, 0.14% and 0.41%, respectively. The incidence of stroke was 1.2% (3 of 250) in direct CAS with transcervical access and 1.02% (5 of 489) in CAS under reversed flow (<italic>P</italic> = not significant). Transient ischemic attack occurred in 20 patients (2.7%)[<xref rid="B31" ref-type="bibr">31</xref>].</p></sec><sec><title>HEAD-TO-HEAD COMPARISON/COMBINATION OF STRATEGIES</title><p>Several studies have compared/combined the various proposed adjuncts to improve CAS outcomes in an attempt to identify those measures that would help improve CAS results to a greater extent. A study from Argentina compared transradial <italic>vs</italic> transfemoral CAS[<xref rid="B32" ref-type="bibr">32</xref>]. A total of 775 consecutive patients undergoing CAS during 16 years were included (101 transradial <italic>vs</italic> 674 transfemoral). The primary combined end-point was in-hospital major adverse cardiac and cerebral events, whereas secondary end-points included angiographic outcome after the procedure and cross-over rate to another puncture site. Angiographic success was achieved in all 775 patients. There was a significant difference in cross-over rate (4.9% <italic>vs</italic> 0%, for the transradial <italic>vs</italic> the transfemoral approach, respectively; <italic>P</italic> &#x0003c; 0.05), but not in the incidence of in-hospital major adverse cardiac and cerebral events (2% <italic>vs</italic> 3.6%, for the transradial <italic>vs</italic> transfemoral approach, respectively; <italic>P</italic> = not significant)[<xref rid="B32" ref-type="bibr">32</xref>]. It was concluded that both approaches are safe and efficacious. These results verified the results of an earlier study[<xref rid="B33" ref-type="bibr">33</xref>].</p><p>An earlier study from Atlanta, Georgia, United States compared revascularization outcomes after CEA (<italic>n</italic> = 226) <italic>vs</italic> CAS with a distal filter EPD (<italic>n</italic> = 216) <italic>vs</italic> CAS with a proximal flow reversal system (<italic>n</italic> = 53)[<xref rid="B34" ref-type="bibr">34</xref>]. The 3 groups did not differ in the overall composite end-point of death, cerebrovascular accident and MI (4% <italic>vs</italic> 5.1% <italic>vs</italic> 0%, respectively; <italic>P</italic> = 0.1) or any individual major adverse event[<xref rid="B34" ref-type="bibr">34</xref>]. Overall, patients undergoing CAS with EPD had a greater incidence of minor cerebrovascular accidents than CEA patients (6 <italic>vs</italic> 1, or 3.4% <italic>vs</italic> 0.5%, respectively; <italic>P</italic> = 0.031). This was driven by the increased risk for a cerebrovascular accident for asymptomatic patients. Of note, patients undergoing CAS with flow reversal (<italic>n</italic> = 53) had zero adverse events (minor/major stroke, MI or death)[<xref rid="B34" ref-type="bibr">34</xref>].</p><p>A study from Japan evaluated the effectiveness of the combined use of distal filter protection device [FilterWire EZ (Boston Scientific, Natick, MA)] and the Mo.Ma Ultra (Medtronic, Minneapolis, MN)[<xref rid="B35" ref-type="bibr">35</xref>]. The Mo.Ma Ultra is an EPD for interrupting the anterograde blood flow to the internal carotid artery. This study demonstrated that the combined use of a distal filter protection device and Mo.Ma Ultra could provide a more reliable embolic protection in CAS[<xref rid="B35" ref-type="bibr">35</xref>].</p><p>A study from Italy reported the outcomes of 214 patients undergoing CAS <italic>via</italic> a transradial (<italic>n</italic> = 154) or a transbrachial (<italic>n</italic> = 60) approach with either the Mo.Ma proximal protection (<italic>n</italic> = 61) or the distal filter protection (<italic>n</italic> = 163)[<xref rid="B36" ref-type="bibr">36</xref>]. As a result of technical difficulties in catheterizing the target vessel, crossover to a femoral approach was required in 11 of 153 (7.1%) filter patients, but only in 1 of the 61 (1.6%) Mo.Ma patients. On the other hand, 5 Mo.Ma patients developed acute intolerance to proximal occlusion (4 were subsequently shifted to filter protection). One patient undergoing CAS <italic>via</italic> the transradial approach was shifted to filter because the Mo.Ma system was too short. Overall, CAS was technically successful in 55 of the 60 (90%) Mo.Ma patients and in 142 of the 154 (93%) filter patients. The 30-d major adverse cardiovascular/cerebrovascular events rate did not differ significantly between the 2 groups (0% for Mo.Ma patients <italic>vs</italic> 2.8% for filter patient; <italic>P</italic> = 0.18). There was similarly no difference in radiation exposure between the 2 groups. Major vascular complications occurred in 1 of the 61 (1.6%) Mo.Ma patients and in 3 of the 153 (1.96%) filter patients, respectively (<italic>P</italic> = 0.18). All these complications occurred during the early learning phase of the transbrachial approach. After a mean follow-up of 8.1 &#x000b1; 7.5 mo, chronic radial artery occlusion was detected by Doppler ultrasound in 2 of the 30 (6.6%) Mo.Ma patients and by clinical assessment in 4 of 124 (3.2%) filter patients (<italic>P</italic> = 0.25). The conclusion reached was that CAS with proximal protection <italic>via</italic> a transradial or a transbrachial approach is a safe, feasible and effective technique with low rate of vascular complications[<xref rid="B36" ref-type="bibr">36</xref>].</p><p>A study from Japan compared the effectiveness of the embolization prevention mechanism of 2 types of EPDs - a distal protection balloon (<italic>n</italic> = 82 patients) and a distal protection filter (<italic>n</italic> = 82 patients)[<xref rid="B37" ref-type="bibr">37</xref>]. Positive findings on postoperative diffusion-weighted imaging were found in more patients with distal protection balloon compared with the distal protection filter (34 <italic>vs</italic> 22 patients, or 41.4% <italic>vs</italic> 26.8%, respectively). Furthermore, in the distal protection balloon group there were more strokes than in the distal protection filter group (2 minor and 2 major strokes <italic>vs</italic> 0 strokes, respectively)[<xref rid="B37" ref-type="bibr">37</xref>]. A combination of flow reversal and distal filter may be more effective than either modality alone[<xref rid="B38" ref-type="bibr">38</xref>].</p><p>Controversial results were reported in a small study from Brazil[<xref rid="B39" ref-type="bibr">39</xref>]. This study compared flow reversal <italic>vs</italic> filter protection in 40 patients undergoing CAS using a femoral approach. Compared with flow reversal (<italic>n</italic> = 21), filter protection (<italic>n</italic> = 19) resulted in a reduction in the incidence (15.8% <italic>vs</italic> 47.6%, respectively; <italic>P</italic> = 0.03), number (0.73 <italic>vs</italic> 2.6, respectively; <italic>P</italic> = 0.05) and size (0.81 mm <italic>vs</italic> 2.23 mm, respectively; <italic>P</italic> = 0.05) of new ischemic brain lesions[<xref rid="B39" ref-type="bibr">39</xref>]. Flow reversal was associated with a tendency toward increased incidence of ipsilateral ischemic lesions more than those who had filter protection (70% <italic>vs</italic> 0.0%, respectively; <italic>P</italic> = 0.07). In addition, flow reversal showed a greater tendency toward increased incidence of ipsilateral lesions than bilateral (70% <italic>vs</italic> 30%, respectively; <italic>P</italic> = 0.07)[<xref rid="B39" ref-type="bibr">39</xref>]. As the authors mentioned, this trial was the first to show better results using filter protection than a proximal protective technique during CAS. The authors attributed these good results to their considerable operator experience with CAS, the general anesthesia (which minimized the risk of movement accidents) and to the filter protection device profile[<xref rid="B39" ref-type="bibr">39</xref>].</p></sec><sec><title>ADVANCES WITH STENT DESIGN</title><p>Several important advances in stent design have also lead to improved CAS outcomes. For instance, the Inspire MD technology (Tel Aviv, Israel) includes a bare-metal stent (Inspire MD C-Guard stent) covered by a micron level mesh (MicroNet). Preliminary results appear encouraging[<xref rid="B40" ref-type="bibr">40</xref>]. A prospective multicenter study, the C-Guard CARotid Embolic protection using microNET trial evaluated the feasibility of the C-Guard carotid embolic protective stent system[<xref rid="B41" ref-type="bibr">41</xref>]. This is a novel thin-strut nitinol stent combined with a polyethylene terephthalate mesh covering. This study reported a 0%3 0-d major adverse cardiac or cerebrovascular events rate in 30 patients[<xref rid="B41" ref-type="bibr">41</xref>]. Another stent that has demonstrated promising results is the double-layer CASPER-RX stent[<xref rid="B42" ref-type="bibr">42</xref>]. Finally, the Roadsaver Micromesh stent is a novel nitinol double-layer micromesh stent. Preliminary results from high-volume centres showing a low incidence of embolic events and new ipsilateral ischemic brain lesions are encouraging[<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B44" ref-type="bibr">44</xref>].</p><p>During CAS, debris is often trapped in stent interstices. When flow is restored following CAS, the trapped debris may prolapse through the stent struts and result in delayed cerebral embolization[<xref rid="B45" ref-type="bibr">45</xref>]. Three companies (Roadsaver<sup>TM</sup> Micromesh Carotid Stent, Terumo, Japan; C-Guard<sup>TM</sup> MicroNet-Covered Embolic Prevention Stent System, InspireMD, Boston, MA, United States; and Scaffold Stent, W.L. Gore and Associates, Flagstaff, AZ, United States) are evaluating membrane or mesh covered carotid stents with smaller interstices to prevent such delayed strokes[<xref rid="B45" ref-type="bibr">45</xref>].</p><p>The advances in carotid stent material and the new types of stents introduced in the market are beyond the scope of this review and are more extensively described elsewhere[<xref rid="B46" ref-type="bibr">46</xref>].</p></sec><sec><title>CONCLUSION</title><p>The battle for CAS is not lost[<xref rid="B47" ref-type="bibr">47</xref>]. The long-term results of the Carotid Revascularization Endarterectomy <italic>vs</italic> Stenting Trial did not show a significant difference in periprocedural stroke, MI or death and subsequent ipsilateral stroke between symptomatic and asymptomatic patients undergoing CAS or CEA[<xref rid="B48" ref-type="bibr">48</xref>] Similarly, the Asymptomatic Carotid Trial demonstrated non-inferiority for CAS compared with CEA for asymptomatic patients with respect to the primary composite end-point of 30-d death, stroke or MI and ipsilateral stroke within 1 year[<xref rid="B49" ref-type="bibr">49</xref>]. New devices, membrane- and mesh-covered stents, alternative approaches and a combination of EPDs are tools in the armamentarium of CAS to improve its results. There is more to see in the future and we will all be awaiting the results of new trials incorporating the advances in CAS technology.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p>Conflict-of-interest statement: None.</p></fn><fn><p>Manuscript source: Invited manuscript</p></fn><fn><p>Specialty type: Cardiac and cardiovascular systems</p></fn><fn><p>Country of origin: United Kingdom</p></fn><fn><p>Peer-review report classification</p></fn><fn><p>Grade A (Excellent): 0</p></fn><fn><p>Grade B (Very good): B</p></fn><fn><p>Grade C (Good): C, C, C</p></fn><fn><p>Grade D (Fair): 0</p></fn><fn><p>Grade E (Poor): 0</p></fn><fn><p>Peer-review started: December 16, 2016</p></fn><fn><p>First decision: January 20, 2017</p></fn><fn><p>Article in press: March 22, 2017</p></fn><fn><p>P- Reviewer: Jiang XJ, Setacci C, Soliman EZ, Tomassini F S- Editor: Kong JX L- Editor: A E- Editor: Wu HL</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naylor</surname><given-names>AR</given-names></name><name><surname>Bolia</surname><given-names>A</given-names></name><name><surname>Abbott</surname><given-names>RJ</given-names></name><name><surname>Pye</surname><given-names>IF</given-names></name><name><surname>Smith</surname><given-names>J</given-names></name><name><surname>Lennard</surname><given-names>N</given-names></name><name><surname>Lloyd</surname><given-names>AJ</given-names></name><name><surname>London</surname><given-names>NJ</given-names></name><name><surname>Bell</surname><given-names>PR</given-names></name></person-group><article-title>Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial</article-title><source>J Vasc Surg</source><year>1998</year><volume>28</volume><fpage>326</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">9719328</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ledwoch</surname><given-names>J</given-names></name><name><surname>Staubach</surname><given-names>S</given-names></name><name><surname>Segerer</surname><given-names>M</given-names></name><name><surname>Strohm</surname><given-names>H</given-names></name><name><surname>Mudra</surname><given-names>H</given-names></name></person-group><article-title>Incidence and risk factors of embolized particles in carotid artery stenting and association with clinical outcome</article-title><source>Int J Cardiol</source><year>2017</year><volume>227</volume><fpage>550</fpage><lpage>555</lpage><pub-id pub-id-type="pmid">27829527</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hornung</surname><given-names>M</given-names></name><name><surname>Franke</surname><given-names>J</given-names></name><name><surname>Bertog</surname><given-names>SC</given-names></name><name><surname>Gafoor</surname><given-names>S</given-names></name><name><surname>Grunwald</surname><given-names>I</given-names></name><name><surname>Sievert</surname><given-names>H</given-names></name></person-group><article-title>Initial Experience Using the Gore Embolic Filter in Carotid Interventions</article-title><source>J Invasive Cardiol</source><year>2016</year><volume>28</volume><fpage>334</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">27466274</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nii</surname><given-names>K</given-names></name><name><surname>Tsutsumi</surname><given-names>M</given-names></name><name><surname>Maeda</surname><given-names>H</given-names></name><name><surname>Aikawa</surname><given-names>H</given-names></name><name><surname>Inoue</surname><given-names>R</given-names></name><name><surname>Eto</surname><given-names>A</given-names></name><name><surname>Sakamoto</surname><given-names>K</given-names></name><name><surname>Mitsutake</surname><given-names>T</given-names></name><name><surname>Hanada</surname><given-names>H</given-names></name><name><surname>Kazekawa</surname><given-names>K</given-names></name></person-group><article-title>Comparison of Flow Impairment during Carotid Artery Stenting Using Two Types of Eccentric Filter Embolic Protection Devices</article-title><source>Neurol Med Chir (Tokyo)</source><year>2016</year><volume>56</volume><fpage>759</fpage><lpage>765</lpage><pub-id pub-id-type="pmid">27319302</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iko</surname><given-names>M</given-names></name><name><surname>Aikawa</surname><given-names>H</given-names></name><name><surname>Go</surname><given-names>Y</given-names></name><name><surname>Nakai</surname><given-names>K</given-names></name><name><surname>Tsutsumi</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>I</given-names></name><name><surname>Mizokami</surname><given-names>T</given-names></name><name><surname>Sakamoto</surname><given-names>K</given-names></name><name><surname>Inoue</surname><given-names>R</given-names></name><name><surname>Mitsutake</surname><given-names>T</given-names></name><etal/></person-group><article-title>Treatment outcomes of carotid artery stenting with two types of distal protection filter device</article-title><source>Springerplus</source><year>2014</year><volume>3</volume><fpage>132</fpage><pub-id pub-id-type="pmid">25674435</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atchaneeyasakul</surname><given-names>K</given-names></name><name><surname>Khandelwal</surname><given-names>P</given-names></name><name><surname>Ambekar</surname><given-names>S</given-names></name><name><surname>Ramdas</surname><given-names>K</given-names></name><name><surname>Guada</surname><given-names>L</given-names></name><name><surname>Yavagal</surname><given-names>D</given-names></name></person-group><article-title>Safety Outcomes Using a Proximal Protection Device in Carotid Stenting of Long Carotid Stenoses</article-title><source>Interv Neurol</source><year>2016</year><volume>5</volume><fpage>123</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">27781040</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montorsi</surname><given-names>P</given-names></name><name><surname>Caputi</surname><given-names>L</given-names></name><name><surname>Galli</surname><given-names>S</given-names></name><name><surname>Ciceri</surname><given-names>E</given-names></name><name><surname>Ballerini</surname><given-names>G</given-names></name><name><surname>Agrifoglio</surname><given-names>M</given-names></name><name><surname>Ravagnani</surname><given-names>P</given-names></name><name><surname>Trabattoni</surname><given-names>D</given-names></name><name><surname>Pontone</surname><given-names>G</given-names></name><name><surname>Fabbiocchi</surname><given-names>F</given-names></name><etal/></person-group><article-title>Microembolization during carotid artery stenting in patients with high-risk, lipid-rich plaque. A randomized trial of proximal versus distal cerebral protection</article-title><source>J Am Coll Cardiol</source><year>2011</year><volume>58</volume><fpage>1656</fpage><lpage>1663</lpage><pub-id pub-id-type="pmid">21982309</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Diederich</surname><given-names>KW</given-names></name><name><surname>Scheinert</surname><given-names>S</given-names></name><name><surname>Br&#x000e4;unlich</surname><given-names>S</given-names></name><name><surname>Olenburger</surname><given-names>T</given-names></name><name><surname>Biamino</surname><given-names>G</given-names></name><name><surname>Schuler</surname><given-names>G</given-names></name><name><surname>Scheinert</surname><given-names>D</given-names></name></person-group><article-title>Effect of two different neuroprotection systems on microembolization during carotid artery stenting</article-title><source>J Am Coll Cardiol</source><year>2004</year><volume>44</volume><fpage>1966</fpage><lpage>1969</lpage><pub-id pub-id-type="pmid">15542277</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bijuklic</surname><given-names>K</given-names></name><name><surname>Wandler</surname><given-names>A</given-names></name><name><surname>Hazizi</surname><given-names>F</given-names></name><name><surname>Schofer</surname><given-names>J</given-names></name></person-group><article-title>The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting): a prospective randomized trial</article-title><source>J Am Coll Cardiol</source><year>2012</year><volume>59</volume><fpage>1383</fpage><lpage>1389</lpage><pub-id pub-id-type="pmid">22284330</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moody</surname><given-names>DM</given-names></name><name><surname>Bell</surname><given-names>MA</given-names></name><name><surname>Challa</surname><given-names>VR</given-names></name><name><surname>Johnston</surname><given-names>WE</given-names></name><name><surname>Prough</surname><given-names>DS</given-names></name></person-group><article-title>Brain microemboli during cardiac surgery or aortography</article-title><source>Ann Neurol</source><year>1990</year><volume>28</volume><fpage>477</fpage><lpage>486</lpage><pub-id pub-id-type="pmid">2252360</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapp</surname><given-names>JH</given-names></name><name><surname>Pan</surname><given-names>XM</given-names></name><name><surname>Sharp</surname><given-names>FR</given-names></name><name><surname>Shah</surname><given-names>DM</given-names></name><name><surname>Wille</surname><given-names>GA</given-names></name><name><surname>Velez</surname><given-names>PM</given-names></name><name><surname>Troyer</surname><given-names>A</given-names></name><name><surname>Higashida</surname><given-names>RT</given-names></name><name><surname>Saloner</surname><given-names>D</given-names></name></person-group><article-title>Atheroemboli to the brain: size threshold for causing acute neuronal cell death</article-title><source>J Vasc Surg</source><year>2000</year><volume>32</volume><fpage>68</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">10876208</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coggia</surname><given-names>M</given-names></name><name><surname>Go&#x000eb;au-Brissonni&#x000e8;re</surname><given-names>O</given-names></name><name><surname>Duval</surname><given-names>JL</given-names></name><name><surname>Leschi</surname><given-names>JP</given-names></name><name><surname>Letort</surname><given-names>M</given-names></name><name><surname>Nagel</surname><given-names>MD</given-names></name></person-group><article-title>Embolic risk of the different stages of carotid bifurcation balloon angioplasty: an experimental study</article-title><source>J Vasc Surg</source><year>2000</year><volume>31</volume><fpage>550</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">10709069</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stabile</surname><given-names>E</given-names></name><name><surname>Salemme</surname><given-names>L</given-names></name><name><surname>Sorropago</surname><given-names>G</given-names></name><name><surname>Tesorio</surname><given-names>T</given-names></name><name><surname>Nammas</surname><given-names>W</given-names></name><name><surname>Miranda</surname><given-names>M</given-names></name><name><surname>Popusoi</surname><given-names>G</given-names></name><name><surname>Cioppa</surname><given-names>A</given-names></name><name><surname>Ambrosini</surname><given-names>V</given-names></name><name><surname>Cota</surname><given-names>L</given-names></name><etal/></person-group><article-title>Proximal endovascular occlusion for carotid artery stenting: results from a prospective registry of 1,300 patients</article-title><source>J Am Coll Cardiol</source><year>2010</year><volume>55</volume><fpage>1661</fpage><lpage>1667</lpage><pub-id pub-id-type="pmid">20394868</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stabile</surname><given-names>E</given-names></name><name><surname>Sannino</surname><given-names>A</given-names></name><name><surname>Schiattarella</surname><given-names>GG</given-names></name><name><surname>Gargiulo</surname><given-names>G</given-names></name><name><surname>Toscano</surname><given-names>E</given-names></name><name><surname>Brevetti</surname><given-names>L</given-names></name><name><surname>Scudiero</surname><given-names>F</given-names></name><name><surname>Giugliano</surname><given-names>G</given-names></name><name><surname>Perrino</surname><given-names>C</given-names></name><name><surname>Trimarco</surname><given-names>B</given-names></name><etal/></person-group><article-title>Cerebral embolic lesions detected with diffusion-weighted magnetic resonance imaging following carotid artery stenting: a meta-analysis of 8 studies comparing filter cerebral protection and proximal balloon occlusion</article-title><source>JACC Cardiovasc Interv</source><year>2014</year><volume>7</volume><fpage>1177</fpage><lpage>1183</lpage><pub-id pub-id-type="pmid">25240544</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mokin</surname><given-names>M</given-names></name><name><surname>Dumont</surname><given-names>TM</given-names></name><name><surname>Chi</surname><given-names>JM</given-names></name><name><surname>Mangan</surname><given-names>CJ</given-names></name><name><surname>Kass-Hout</surname><given-names>T</given-names></name><name><surname>Sorkin</surname><given-names>GC</given-names></name><name><surname>Snyder</surname><given-names>KV</given-names></name><name><surname>Hopkins</surname><given-names>LN</given-names></name><name><surname>Siddiqui</surname><given-names>AH</given-names></name><name><surname>Levy</surname><given-names>EI</given-names></name></person-group><article-title>Proximal versus distal protection during carotid artery stenting: analysis of the two treatment approaches and associated clinical outcomes</article-title><source>World Neurosurg</source><year>2014</year><volume>81</volume><fpage>543</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">24355517</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassese</surname><given-names>S</given-names></name><name><surname>Ndrepepa</surname><given-names>G</given-names></name><name><surname>King</surname><given-names>LA</given-names></name><name><surname>Nerad</surname><given-names>M</given-names></name><name><surname>Schunkert</surname><given-names>H</given-names></name><name><surname>Kastrati</surname><given-names>A</given-names></name><name><surname>Ott</surname><given-names>I</given-names></name><name><surname>Fusaro</surname><given-names>M</given-names></name></person-group><article-title>Proximal occlusion versus distal filter for cerebral protection during carotid stenting: updated meta-analysis of randomised and observational MRI studies</article-title><source>EuroIntervention</source><year>2015</year><volume>11</volume><fpage>238</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">25735933</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omran</surname><given-names>J</given-names></name><name><surname>Mahmud</surname><given-names>E</given-names></name><name><surname>White</surname><given-names>CJ</given-names></name><name><surname>Aronow</surname><given-names>HD</given-names></name><name><surname>Drachman</surname><given-names>DE</given-names></name><name><surname>Gray</surname><given-names>W</given-names></name><name><surname>Abdullah</surname><given-names>O</given-names></name><name><surname>Abu-Fadel</surname><given-names>M</given-names></name><name><surname>Firwana</surname><given-names>B</given-names></name><name><surname>Mishkel</surname><given-names>G</given-names></name><etal/></person-group><article-title>Proximal balloon occlusion versus distal filter protection in carotid artery stenting: A meta-analysis and review of the literature</article-title><source>Catheter Cardiovasc Interv</source><year>2016</year><comment>Nov 12; Epub ahead of print</comment></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giri</surname><given-names>J</given-names></name><name><surname>Parikh</surname><given-names>SA</given-names></name><name><surname>Kennedy</surname><given-names>KF</given-names></name><name><surname>Weinberg</surname><given-names>I</given-names></name><name><surname>Donaldson</surname><given-names>C</given-names></name><name><surname>Hawkins</surname><given-names>BM</given-names></name><name><surname>McCormick</surname><given-names>DJ</given-names></name><name><surname>Jackson</surname><given-names>B</given-names></name><name><surname>Armstrong</surname><given-names>EJ</given-names></name><name><surname>Ramchand</surname><given-names>P</given-names></name><etal/></person-group><article-title>Proximal versus distal embolic protection for carotid artery stenting: a national cardiovascular data registry analysis</article-title><source>JACC Cardiovasc Interv</source><year>2015</year><volume>8</volume><fpage>609</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">25907088</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parodi</surname><given-names>JC</given-names></name><name><surname>La Mura</surname><given-names>R</given-names></name><name><surname>Ferreira</surname><given-names>LM</given-names></name><name><surname>Mendez</surname><given-names>MV</given-names></name><name><surname>Cers&#x000f3;simo</surname><given-names>H</given-names></name><name><surname>Sch&#x000f6;nholz</surname><given-names>C</given-names></name><name><surname>Garelli</surname><given-names>G</given-names></name></person-group><article-title>Initial evaluation of carotid angioplasty and stenting with three different cerebral protection devices</article-title><source>J Vasc Surg</source><year>2000</year><volume>32</volume><fpage>1127</fpage><lpage>1136</lpage><pub-id pub-id-type="pmid">11107084</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Criado</surname><given-names>E</given-names></name><name><surname>Doblas</surname><given-names>M</given-names></name><name><surname>Fontcuberta</surname><given-names>J</given-names></name><name><surname>Orgaz</surname><given-names>A</given-names></name><name><surname>Flores</surname><given-names>A</given-names></name></person-group><article-title>Transcervical carotid artery angioplasty and stenting with carotid flow reversal: surgical technique</article-title><source>Ann Vasc Surg</source><year>2004</year><volume>18</volume><fpage>257</fpage><lpage>261</lpage><pub-id pub-id-type="pmid">15253268</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>B</given-names></name><name><surname>Matas</surname><given-names>M</given-names></name><name><surname>Ribo</surname><given-names>M</given-names></name><name><surname>Maeso</surname><given-names>J</given-names></name><name><surname>Yugueros</surname><given-names>X</given-names></name><name><surname>Alvarez-Sabin</surname><given-names>J</given-names></name></person-group><article-title>Transcervical carotid stenting with flow reversal is a safe technique for high-risk patients older than 70 years</article-title><source>J Vasc Surg</source><year>2012</year><volume>55</volume><fpage>978</fpage><lpage>984</lpage><pub-id pub-id-type="pmid">22322116</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>DW</given-names></name><name><surname>Schubart</surname><given-names>PJ</given-names></name><name><surname>Veith</surname><given-names>FJ</given-names></name><name><surname>Zarins</surname><given-names>CK</given-names></name></person-group><article-title>A new approach to carotid angioplasty and stenting with transcervical occlusion and protective shunting: Why it may be a better carotid artery intervention</article-title><source>J Vasc Surg</source><year>2004</year><volume>39</volume><fpage>994</fpage><lpage>1002</lpage><pub-id pub-id-type="pmid">15111851</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinter</surname><given-names>L</given-names></name><name><surname>Ribo</surname><given-names>M</given-names></name><name><surname>Loh</surname><given-names>C</given-names></name><name><surname>Lane</surname><given-names>B</given-names></name><name><surname>Roberts</surname><given-names>T</given-names></name><name><surname>Chou</surname><given-names>TM</given-names></name><name><surname>Kolvenbach</surname><given-names>RR</given-names></name></person-group><article-title>Safety and feasibility of a novel transcervical access neuroprotection system for carotid artery stenting in the PROOF Study</article-title><source>J Vasc Surg</source><year>2011</year><volume>54</volume><fpage>1317</fpage><lpage>1323</lpage><pub-id pub-id-type="pmid">21658889</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><collab>Leal I, Orgaz A, Flores &#x000c1;, Gil J, Rodr&#x000ed;guez R, Peinado J, Criado E, Doblas M</collab><article-title>A diffusion-weighted magnetic resonance imaging-based study of transcervical carotid stenting with flow reversal versus transfemoral filter protection</article-title><source>J Vasc Surg</source><year>2012</year><volume>56</volume><fpage>1585</fpage><lpage>1590</lpage><pub-id pub-id-type="pmid">22960021</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goode</surname><given-names>SD</given-names></name><name><surname>Hoggard</surname><given-names>N</given-names></name><name><surname>Macdonald</surname><given-names>S</given-names></name><name><surname>Evans</surname><given-names>DH</given-names></name><name><surname>Cleveland</surname><given-names>TJ</given-names></name><name><surname>Gaines</surname><given-names>PA</given-names></name></person-group><article-title>Assessment of reverse flow as a means of cerebral protection during carotid artery stent placement with diffusion-weighted and transcranial Doppler imaging</article-title><source>J Vasc Interv Radiol</source><year>2013</year><volume>24</volume><fpage>528</fpage><lpage>533</lpage><pub-id pub-id-type="pmid">23462063</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plessers</surname><given-names>M</given-names></name><name><surname>Van Herzeele</surname><given-names>I</given-names></name><name><surname>Hemelsoet</surname><given-names>D</given-names></name><name><surname>Patel</surname><given-names>N</given-names></name><name><surname>Chung</surname><given-names>EM</given-names></name><name><surname>Vingerhoets</surname><given-names>G</given-names></name><name><surname>Vermassen</surname><given-names>F</given-names></name></person-group><article-title>Transcervical Carotid Stenting With Dynamic Flow Reversal Demonstrates Embolization Rates Comparable to Carotid Endarterectomy</article-title><source>J Endovasc Ther</source><year>2016</year><volume>23</volume><fpage>249</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">26794908</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paraskevas</surname><given-names>KI</given-names></name><name><surname>Veith</surname><given-names>FJ</given-names></name><name><surname>Parodi</surname><given-names>JC</given-names></name></person-group><article-title>Commentary: Transcervical Carotid Artery Stenting (CAS) With Flow Reversal: A Promising Technique for the Reduction of Strokes Associated With CAS</article-title><source>J Endovasc Ther</source><year>2016</year><volume>23</volume><fpage>255</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">26984815</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voeks</surname><given-names>JH</given-names></name><name><surname>Howard</surname><given-names>G</given-names></name><name><surname>Roubin</surname><given-names>GS</given-names></name><name><surname>Malas</surname><given-names>MB</given-names></name><name><surname>Cohen</surname><given-names>DJ</given-names></name><name><surname>Sternbergh</surname><given-names>WC</given-names></name><name><surname>Aronow</surname><given-names>HD</given-names></name><name><surname>Eskandari</surname><given-names>MK</given-names></name><name><surname>Sheffet</surname><given-names>AJ</given-names></name><name><surname>Lal</surname><given-names>BK</given-names></name><etal/></person-group><article-title>Age and outcomes after carotid stenting and endarterectomy: the carotid revascularization endarterectomy versus stenting trial</article-title><source>Stroke</source><year>2011</year><volume>42</volume><fpage>3484</fpage><lpage>3490</lpage><pub-id pub-id-type="pmid">21980205</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwolek</surname><given-names>CJ</given-names></name><name><surname>Jaff</surname><given-names>MR</given-names></name><name><surname>Leal</surname><given-names>JI</given-names></name><name><surname>Hopkins</surname><given-names>LN</given-names></name><name><surname>Shah</surname><given-names>RM</given-names></name><name><surname>Hanover</surname><given-names>TM</given-names></name><name><surname>Macdonald</surname><given-names>S</given-names></name><name><surname>Cambria</surname><given-names>RP</given-names></name></person-group><article-title>Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal</article-title><source>J Vasc Surg</source><year>2015</year><volume>62</volume><fpage>1227</fpage><lpage>1234</lpage><pub-id pub-id-type="pmid">26506270</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergeron</surname><given-names>P</given-names></name></person-group><article-title>Direct percutaneous carotid access for carotid angioplasty and stenting</article-title><source>J Endovasc Ther</source><year>2015</year><volume>22</volume><fpage>135</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">25775694</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sfyroeras</surname><given-names>GS</given-names></name><name><surname>Moulakakis</surname><given-names>KG</given-names></name><name><surname>Markatis</surname><given-names>F</given-names></name><name><surname>Antonopoulos</surname><given-names>CN</given-names></name><name><surname>Antoniou</surname><given-names>GA</given-names></name><name><surname>Kakisis</surname><given-names>JD</given-names></name><name><surname>Brountzos</surname><given-names>EN</given-names></name><name><surname>Liapis</surname><given-names>CD</given-names></name></person-group><article-title>Results of carotid artery stenting with transcervical access</article-title><source>J Vasc Surg</source><year>2013</year><volume>58</volume><fpage>1402</fpage><lpage>1407</lpage><pub-id pub-id-type="pmid">24074938</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendiz</surname><given-names>OA</given-names></name><name><surname>Fava</surname><given-names>C</given-names></name><name><surname>Lev</surname><given-names>G</given-names></name><name><surname>Caponi</surname><given-names>G</given-names></name><name><surname>Valdivieso</surname><given-names>L</given-names></name></person-group><article-title>Transradial Versus Transfemoral Carotid Artery Stenting: A 16-Year Single-Center Experience</article-title><source>J Interv Cardiol</source><year>2016</year><volume>29</volume><fpage>588</fpage><lpage>593</lpage><pub-id pub-id-type="pmid">27634206</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruzsa</surname><given-names>Z</given-names></name><name><surname>Nemes</surname><given-names>B</given-names></name><name><surname>Pint&#x000e9;r</surname><given-names>L</given-names></name><name><surname>Berta</surname><given-names>B</given-names></name><name><surname>T&#x000f3;th</surname><given-names>K</given-names></name><name><surname>Teleki</surname><given-names>B</given-names></name><name><surname>Nardai</surname><given-names>S</given-names></name><name><surname>Jambrik</surname><given-names>Z</given-names></name><name><surname>Szab&#x000f3;</surname><given-names>G</given-names></name><name><surname>Kolvenbach</surname><given-names>R</given-names></name><etal/></person-group><article-title>A randomised comparison of transradial and transfemoral approach for carotid artery stenting: RADCAR (RADial access for CARotid artery stenting) study</article-title><source>EuroIntervention</source><year>2014</year><volume>10</volume><fpage>381</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">25042266</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brewster</surname><given-names>LP</given-names></name><name><surname>Beaulieu</surname><given-names>R</given-names></name><name><surname>Corriere</surname><given-names>MA</given-names></name><name><surname>Veeraswamy</surname><given-names>R</given-names></name><name><surname>Niazi</surname><given-names>KA</given-names></name><name><surname>Robertson</surname><given-names>G</given-names></name><name><surname>Dodson</surname><given-names>TF</given-names></name><name><surname>Kasirajan</surname><given-names>K</given-names></name></person-group><article-title>Carotid revascularization outcomes comparing distal filters, flow reversal, and endarterectomy</article-title><source>J Vasc Surg</source><year>2011</year><volume>54</volume><fpage>1000</fpage><lpage>1004; discussion 1000-1004</lpage><pub-id pub-id-type="pmid">21871772</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moteki</surname><given-names>Y</given-names></name><name><surname>Niimi</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Shima</surname><given-names>S</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name></person-group><article-title>Effectiveness of the Combined Use of Distal Filter Protection Device and Mo.Ma Ultra: Technical Note</article-title><source>J Stroke Cerebrovasc Dis</source><year>2016</year><volume>25</volume><fpage>2627</fpage><lpage>2631</lpage><pub-id pub-id-type="pmid">27476338</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montorsi</surname><given-names>P</given-names></name><name><surname>Galli</surname><given-names>S</given-names></name><name><surname>Ravagnani</surname><given-names>PM</given-names></name><name><surname>Tresoldi</surname><given-names>S</given-names></name><name><surname>Teruzzi</surname><given-names>G</given-names></name><name><surname>Caputi</surname><given-names>L</given-names></name><name><surname>Trabattoni</surname><given-names>D</given-names></name><name><surname>Fabbiocchi</surname><given-names>F</given-names></name><name><surname>Calligaris</surname><given-names>G</given-names></name><name><surname>Grancini</surname><given-names>L</given-names></name><etal/></person-group><article-title>Carotid Artery Stenting With Proximal Embolic Protection via a Transradial or Transbrachial Approach: Pushing the Boundaries of the Technique While Maintaining Safety and Efficacy</article-title><source>J Endovasc Ther</source><year>2016</year><volume>23</volume><fpage>549</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">27270761</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iko</surname><given-names>M</given-names></name><name><surname>Tsutsumi</surname><given-names>M</given-names></name><name><surname>Aikawa</surname><given-names>H</given-names></name><name><surname>Matsumoto</surname><given-names>Y</given-names></name><name><surname>Go</surname><given-names>Y</given-names></name><name><surname>Nii</surname><given-names>K</given-names></name><name><surname>Abe</surname><given-names>G</given-names></name><name><surname>Ye</surname><given-names>I</given-names></name><name><surname>Nomoto</surname><given-names>Y</given-names></name><name><surname>Kazekawa</surname><given-names>K</given-names></name></person-group><article-title>Distal protection filter device efficacy with carotid artery stenting: comparison between a distal protection filter and a distal protection balloon</article-title><source>Jpn J Radiol</source><year>2013</year><volume>31</volume><fpage>45</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">23179785</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harada</surname><given-names>K</given-names></name><name><surname>Kakumoto</surname><given-names>K</given-names></name><name><surname>Morioka</surname><given-names>J</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Fukuyama</surname><given-names>K</given-names></name></person-group><article-title>Combination of flow reversal and distal filter for cerebral protection during carotid artery stenting</article-title><source>Ann Vasc Surg</source><year>2014</year><volume>28</volume><fpage>651</fpage><lpage>658</lpage><pub-id pub-id-type="pmid">24378246</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><collab>Castro-Afonso LH, Abud LG, Rolo JG, Santos AC, Oliveira Ld, Barreira CM, Velasco TR, Pontes-Neto OM, Abud DG</collab><article-title>Flow reversal versus filter protection: a pilot carotid artery stenting randomized trial</article-title><source>Circ Cardiovasc Interv</source><year>2013</year><volume>6</volume><fpage>552</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">24084627</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzaccaro</surname><given-names>D</given-names></name><name><surname>Occhiuto</surname><given-names>MT</given-names></name><name><surname>Righini</surname><given-names>P</given-names></name><name><surname>Malacrida</surname><given-names>G</given-names></name><name><surname>Nano</surname><given-names>G</given-names></name></person-group><article-title>Initial experience with the inspire MD C-Guard stent in the treatment of carotid artery disease</article-title><source>J Cardiovasc Surg (Torino)</source><year>2016</year><volume>57</volume><fpage>474</fpage><lpage>478</lpage></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schofer</surname><given-names>J</given-names></name><name><surname>Musia&#x00142;ek</surname><given-names>P</given-names></name><name><surname>Bijuklic</surname><given-names>K</given-names></name><name><surname>Kolvenbach</surname><given-names>R</given-names></name><name><surname>Trystula</surname><given-names>M</given-names></name><name><surname>Siudak</surname><given-names>Z</given-names></name><name><surname>Sievert</surname><given-names>H</given-names></name></person-group><article-title>A Prospective, Multicenter Study of a Novel Mesh-Covered Carotid Stent: The CGuard CARENET Trial (Carotid Embolic Protection Using MicroNet)</article-title><source>JACC Cardiovasc Interv</source><year>2015</year><volume>8</volume><fpage>1229</fpage><lpage>1234</lpage><pub-id pub-id-type="pmid">26292586</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wissgott</surname><given-names>C</given-names></name><name><surname>Schmidt</surname><given-names>W</given-names></name><name><surname>Brandt</surname><given-names>C</given-names></name><name><surname>Behrens</surname><given-names>P</given-names></name><name><surname>Andresen</surname><given-names>R</given-names></name></person-group><article-title>Preliminary Clinical Results and Mechanical Behavior of a New Double-Layer Carotid Stent</article-title><source>J Endovasc Ther</source><year>2015</year><volume>22</volume><fpage>634</fpage><lpage>639</lpage><pub-id pub-id-type="pmid">26187981</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nerla</surname><given-names>R</given-names></name><name><surname>Castriota</surname><given-names>F</given-names></name><name><surname>Micari</surname><given-names>A</given-names></name><name><surname>Sbarzaglia</surname><given-names>P</given-names></name><name><surname>Secco</surname><given-names>GG</given-names></name><name><surname>Ruffino</surname><given-names>MA</given-names></name><name><surname>de Donato</surname><given-names>G</given-names></name><name><surname>Setacci</surname><given-names>C</given-names></name><name><surname>Cremonesi</surname><given-names>A</given-names></name></person-group><article-title>Carotid artery stenting with a new-generation double-mesh stent in three high-volume Italian centres: clinical results of a multidisciplinary approach</article-title><source>EuroIntervention</source><year>2016</year><volume>12</volume><fpage>e677</fpage><lpage>e683</lpage><pub-id pub-id-type="pmid">27497367</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruffino</surname><given-names>MA</given-names></name><name><surname>Faletti</surname><given-names>R</given-names></name><name><surname>Bergamasco</surname><given-names>L</given-names></name><name><surname>Fonio</surname><given-names>P</given-names></name><name><surname>Righi</surname><given-names>D</given-names></name></person-group><article-title>Incidence of New Ischaemic Brain Lesions After Carotid Artery Stenting with the Micromesh Roadsaver Carotid Artery Stent: A Prospective Single-Centre Study</article-title><source>Cardiovasc Intervent Radiol</source><year>2016</year><volume>39</volume><fpage>1541</fpage><lpage>1549</lpage><pub-id pub-id-type="pmid">27571985</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cremonesi</surname><given-names>A</given-names></name><name><surname>Castriota</surname><given-names>F</given-names></name><name><surname>Secco</surname><given-names>GG</given-names></name><name><surname>Macdonald</surname><given-names>S</given-names></name><name><surname>Roffi</surname><given-names>M</given-names></name></person-group><article-title>Carotid artery stenting: an update</article-title><source>Eur Heart J</source><year>2015</year><volume>36</volume><fpage>13</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">25535085</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name></person-group><article-title>The development of carotid stent material</article-title><source>Interv Neurol</source><year>2015</year><volume>3</volume><fpage>67</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">26019710</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paraskevas</surname><given-names>KI</given-names></name><name><surname>Veith</surname><given-names>FJ</given-names></name></person-group><article-title>Techniques and innovations to improve carotid artery stenting outcomes</article-title><source>Int J Cardiol</source><year>2016</year><volume>222</volume><fpage>986</fpage><lpage>987</lpage><pub-id pub-id-type="pmid">27526376</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brott</surname><given-names>TG</given-names></name><name><surname>Howard</surname><given-names>G</given-names></name><name><surname>Roubin</surname><given-names>GS</given-names></name><name><surname>Meschia</surname><given-names>JF</given-names></name><name><surname>Mackey</surname><given-names>A</given-names></name><name><surname>Brooks</surname><given-names>W</given-names></name><name><surname>Moore</surname><given-names>WS</given-names></name><name><surname>Hill</surname><given-names>MD</given-names></name><name><surname>Mantese</surname><given-names>VA</given-names></name><name><surname>Clark</surname><given-names>WM</given-names></name><etal/></person-group><article-title>Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis</article-title><source>N Engl J Med</source><year>2016</year><volume>374</volume><fpage>1021</fpage><lpage>1031</lpage><pub-id pub-id-type="pmid">26890472</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenfield</surname><given-names>K</given-names></name><name><surname>Matsumura</surname><given-names>JS</given-names></name><name><surname>Chaturvedi</surname><given-names>S</given-names></name><name><surname>Riles</surname><given-names>T</given-names></name><name><surname>Ansel</surname><given-names>GM</given-names></name><name><surname>Metzger</surname><given-names>DC</given-names></name><name><surname>Wechsler</surname><given-names>L</given-names></name><name><surname>Jaff</surname><given-names>MR</given-names></name><name><surname>Gray</surname><given-names>W</given-names></name></person-group><article-title>Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis</article-title><source>N Engl J Med</source><year>2016</year><volume>374</volume><fpage>1011</fpage><lpage>1020</lpage><pub-id pub-id-type="pmid">26886419</pub-id></element-citation></ref></ref-list></back></article>